Susquehanna International Group
DNA.WS

Susquehanna International Group’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Susquehanna International Group’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-69,402
Closed -$1.96K – 13349
2024
Q2 		$1.96K Buy
69,402
+15,047
+28% +$808 ﹤0.01% 11852
2024
Q1 		$4.89K Hold
54,355
– – ﹤0.01% 11953
2023
Q4 		$5.72K Sell
54,355
-25,777
-32% -$3.8K ﹤0.01% 12120
2023
Q3 		$18K Buy
80,132
+25,777
+47% +$6.92K ﹤0.01% 11628
2023
Q2 		$14.3K Hold
54,355
– – ﹤0.01% 11701
2023
Q1 		$9.78K Hold
54,355
– – ﹤0.01% 12215
2022
Q4 		$10.9K Hold
54,355
– – ﹤0.01% 11923
2022
Q3 		$39K Hold
54,355
– – ﹤0.01% 12348
2022
Q2 		$29K Sell
54,355
-1,340
-2% -$850 ﹤0.01% 12243
2022
Q1 		$49K Sell
55,695
-4,340
-7% -$4.83K ﹤0.01% 12325
2021
Q4 		$134K Buy
60,035
+16,360
+37% +$52.9K ﹤0.01% 11920
2021
Q3 		$148K Buy
+43,675
New +$156K ﹤0.01% 11808

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Susquehanna International Group's DNA.WS Position: Q3 2024 in Review

Susquehanna International Group sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 69,402 shares — an estimated $1.96K sold.

Susquehanna International Group first reported a position in DNA.WS in Q3 2021 and held it in 12 quarters. The position peaked at $148K in Q3 2021. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • Susquehanna International Group reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 69,402 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $1.96K.
  • Susquehanna International Group first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 12 quarters.
  • Susquehanna International Group's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $148K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.